Exact Mass: 484.4504736
Exact Mass Matches: 484.4504736
Found 181 metabolites which its exact mass value is equals to given mass value 484.4504736,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
DG(8:0/18:0/0:0)
DG(8:0/18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/18:0)
DG(8:0/0:0/18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/i-18:0/0:0)
DG(8:0/i-18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/i-18:0)
DG(8:0/0:0/i-18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/16:0/0:0)
DG(10:0/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/16:0)
DG(10:0/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/i-16:0/0:0)
DG(10:0/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/i-16:0)
DG(10:0/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/14:0/0:0)
DG(12:0/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/14:0)
DG(12:0/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/14:0/0:0)
DG(i-12:0/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/14:0)
DG(i-12:0/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/i-14:0/0:0)
DG(i-12:0/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/i-14:0)
DG(i-12:0/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/i-14:0/0:0)
DG(12:0/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/i-14:0)
DG(12:0/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/13:0/0:0)
DG(13:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/13:0)
DG(13:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/13:0/0:0)
DG(i-13:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/13:0)
DG(i-13:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/i-13:0/0:0)
DG(a-13:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/i-13:0)
DG(a-13:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/a-13:0/0:0)
DG(i-13:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/a-13:0)
DG(i-13:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/13:0/0:0)
DG(a-13:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/13:0)
DG(a-13:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/i-13:0/0:0)
DG(i-13:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/i-13:0)
DG(i-13:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/i-13:0/0:0)
DG(13:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/i-13:0)
DG(13:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/a-13:0/0:0)
DG(13:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/a-13:0)
DG(13:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/a-13:0/0:0)
DG(a-13:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/a-13:0)
DG(a-13:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(14:0/12:0/0:0)
DG(14:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(14:0/0:0/12:0)
DG(14:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/12:0/0:0)
DG(i-14:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/0:0/12:0)
DG(i-14:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/i-12:0/0:0)
DG(i-14:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-14:0/0:0/i-12:0)
DG(i-14:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(14:0/i-12:0/0:0)
DG(14:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(14:0/0:0/i-12:0)
DG(14:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(16:0/10:0/0:0)
DG(16:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(16:0/0:0/10:0)
DG(16:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/10:0/0:0)
DG(i-16:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-16:0/0:0/10:0)
DG(i-16:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:0/8:0/0:0)
DG(18:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:0/0:0/8:0)
DG(18:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-18:0/8:0/0:0)
DG(i-18:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-18:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-18:0/0:0/8:0)
DG(i-18:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
(2E)-{(20S)-20-[formyl(methyl)amino]-5alpha-pregnan-3beta-yl}-3,4-dimethylpent-2-enamide|hookerianamide-D
C31H52N2O2 (484.40285719999997)
Stigmasteroltrimethylsilylether|Trimethylsilylderivat v. Stigmasterol
(3beta)-3-hydroxy-30-propylhopan-31-one|(5R)-5-[(3R,3aS,5aR,5bR,7aR,9S,11aR,13aR,13bS)-eicosahydro-9-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-1H-cyclopenta[a]chrysen-3-yl]hexan-3-one
3beta-methoxy-25-methyl-24-methylenelanost-9(11)-en-21-ol
Heneicosanylserotonin
C31H52N2O2 (484.40285719999997)
Silane, trimethyl[[(3beta)-stigmasta-5,24(28)-dien-3-yl]oxy]-
(3-Carboxy-2-docosanoyloxypropyl)-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(19-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(17-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(11-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(20-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(9-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(8-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(4-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(16-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(6-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(12-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(10-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(18-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(7-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(14-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(13-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(5-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(15-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
[3-Carboxy-2-(3-methylhenicosanoyloxy)propyl]-trimethylazanium
C29H58NO4+ (484.43656080000005)
(1-Hydroxy-3-octanoyloxypropan-2-yl) octadecanoate
Ditridecanoic acid 3-hydroxy-1,2-propanediyl ester
(1-Dodecanoyloxy-3-hydroxypropan-2-yl) tetradecanoate
(1-Hydroxy-3-nonanoyloxypropan-2-yl) heptadecanoate
(1-Hydroxy-3-undecanoyloxypropan-2-yl) pentadecanoate
[(2S)-3-hydroxy-2-undecanoyloxypropyl] pentadecanoate
(1-Heptanoyloxy-3-hydroxypropan-2-yl) nonadecanoate
(1-Hydroxy-3-propanoyloxypropan-2-yl) tricosanoate
(1-Hydroxy-3-pentanoyloxypropan-2-yl) henicosanoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] pentadecanoate
[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] octadecanoate
(3S,4R,9R,11S)-3-methoxy-4-methylnonacosane-9,11-diol
diacylglycerol 26:0
A diglyceride in which the two acyl groups contain a total of 26 carbons and 0 double bonds.
TG(26:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
SiE(4:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1r,3r,6s,7s,8r,11r,12s,15r,16r)-15-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
{[(1r,3ar,3br,7r,9as,9br,11ar)-1-[(2s,3z,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}trimethylsilane
6-methoxy-15-(4-methoxy-6-methyl-5-methylideneheptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane
(2s)-1-o-heptacosanoyl glycerol
{"Ingredient_id": "HBIN006570","Ingredient_name": "(2s)-1-o-heptacosanoyl glycerol","Alias": "NA","Ingredient_formula": "C30H60O4","Ingredient_Smile": "CCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9410","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,3as,3br,5ar,7r,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(2e)-n-[(3s,6s,8s,11r,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-3-hydroxy-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-1(18)-en-6-yl]-2-methylbut-2-enimidic acid
C31H52N2O2 (484.40285719999997)
7-methoxy-1-(4-methoxy-6-methyl-5-methylideneheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
{[1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}trimethylsilane
3a,6,6,9a,11a-pentamethyl-1-(6-methyl-5-methylideneheptan-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
1-[2,5-dimethyl-5-(2-methylbutan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
n-{9a,11a-dimethyl-1-[1-(n-methylformamido)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}-n,3,4-trimethylpent-2-enamide
C31H52N2O2 (484.40285719999997)
(5r)-5-[(3r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-9-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]hexan-3-one
(6z,12s,14s,23z,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-6,23-dien-18-ol
1-(5,6-dimethylhept-6-en-2-yl)-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(1r,3ar,5ar,7s,9as,11ar)-7-methoxy-1-[(2r,4s)-4-methoxy-6-methyl-5-methylideneheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene
(2e,10z)-2-[(6z,9z)-pentadeca-6,9-dien-1-yl]nonadeca-2,10-dienal
(1s,3ar,3br,5ar,9ar,9br,11ar)-1-[(2s,5r)-2,5-dimethyl-5-(2-methylbutan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydrocyclopenta[a]phenanthren-7-one
(2e,10z,13z)-2-[(6z)-pentadec-6-en-1-yl]nonadeca-2,10,13-trienal
(1r,3as,3br,5ar,7r,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylhept-6-en-2-yl]-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
5-{9-hydroxy-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl}hexan-3-one
(1r,3as,3bs,5ar,9as,11ar)-1-[(2r,5s)-5-methoxy-5,6,6-trimethylheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-7-one
(1s,3r,6s,8r,11s,12s,15r,16r)-6-methoxy-15-[(2r,4s)-4-methoxy-6-methyl-5-methylideneheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane
15-(5-ethyl-6-methylheptan-2-yl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate
1-(5-methoxy-5,6,6-trimethylheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-7-one
n-(1-amino-13-carbamimidamido-5-hydroxytridecan-4-yl)-9-carbamimidamidononanimidic acid
C24H52N8O2 (484.42130119999996)
(1r,3as,3br,5ar,7r,9ar,9bs,11ar)-1-[(2r,4e)-5,6-dimethylhept-4-en-2-yl]-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
n-{15-[1-(dimethylamino)ethyl]-3-hydroxy-7,7,12,16-tetramethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadec-1(18)-en-6-yl}-2-methylbut-2-enimidic acid
C31H52N2O2 (484.40285719999997)
1-(5,6-dimethylheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
1-(5,6-dimethylhept-4-en-2-yl)-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(1s,3as,5as,7r,9as,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(2e)-n-[(1s,3as,3br,5as,7s,9as,9bs,11as)-9a,11a-dimethyl-1-[(1s)-1-(n-methylformamido)ethyl]-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-n,3,4-trimethylpent-2-enamide
C31H52N2O2 (484.40285719999997)